Skip to main content
. 2015 Jul 22;6(31):32193–32204. doi: 10.18632/oncotarget.4975

Figure 3. Successful knockdown of XRCC2 in SW480 colorectal cancer cells.

Figure 3

A. Western blotting was used to detect XRCC2 knockdown efficiency in untransfected SW480 cells, SW480 cells transfected with nonsilencing (vector) shRNAs, and SW480 cells transfected with shRNA1 and shRNA2. B. Lower expression of XRCC2 mRNA was detected in XRCC2 knockdown SW480 cells using quantitative real-time PCR.